Results 81 to 90 of about 10,615 (182)

Efficacy of High‐Frequency Transcranial Magnetic Stimulation Therapy for Depression With Insomnia Symptoms: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials

open access: yesBrain and Behavior, Volume 16, Issue 11, November 2026.
It summarizes the key findings: improves sleep quality (SMD0.97) and depressive symptoms(SMD0.61) in depression‐related insomia ABSTRACT Background This meta‐analysis evaluated the efficacy of high‐frequency repetitive transcranial magnetic stimulation (HF‐rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC) in patients with comorbid ...
Wenqing Yang   +5 more
wiley   +1 more source

Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators

open access: yesFrontiers in Neuroscience, 2013
Dual orexin receptor antagonists (DORAs) are a potential treatment for insomnia that function by blocking both the orexin 1 and orexin 2 receptors. The objective of the current study was to further confirm the impact of therapeutic mechanisms targeting ...
Andres D. Ramirez   +16 more
doaj   +1 more source

Advances in Multidimensional Molecular Mechanisms of Epilepsy and Precision Therapy Strategies

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
Epilepsy arises from a multidimensional network imbalance, integrating genetic, inflammatory, and metabolic disruptions. This complexity drives neuronal hyperexcitability and underpins therapeutic challenges. Our review highlights how emerging precision strategies, from targeted molecular therapies to neuromodulation, offer a transformative path toward
Yimin Han   +7 more
wiley   +1 more source

The role of orexin A in the pathogenesis of ischaemic stroke at high altitude

open access: yesExperimental Physiology
Orexin offers protection against cerebral ischaemia–reperfusion injury, with high altitude playing a key role in modulating its expression. This study aimed to investigate the effect of high altitude on orexin expression and its pathophysiological ...
Minxia Zhu   +7 more
doaj   +1 more source

Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review

open access: yesThe American Journal on Addictions, Volume 35, Issue 6, Page 702-726, November 2026.
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas   +10 more
wiley   +1 more source

Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review

open access: yesThe American Journal on Addictions, Volume 35, Issue 6, Page 661-672, November 2026.
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan   +2 more
wiley   +1 more source

Orexinergic–Opioidergic Interactions Within the Nucleus Accumbens in the Modulation of Acute Pain: Evidence From the Tail-Flick Test in Rats

open access: yesJournal of Integrative Neuroscience
Background:The nucleus accumbens (NAc) plays a central role in integrating motivational, reward-related, and nociceptive inputs. Opioid and orexin systems within the NAc are both implicated in pain modulation, yet their functional interaction in acute ...
Mohammad Sajad Jolani   +3 more
doaj   +1 more source

Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor [PDF]

open access: yesJournal of Biological Chemistry, 2003
Sandrine Hilairet   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy